Literature DB >> 7735593

Enhanced retention of asbestos fibers in the airways of human smokers.

A Churg1, B Stevens.   

Abstract

To determine whether cigarette smoke increases the pulmonary retention of asbestos, we compared the asbestos-fiber burden in the airway mucosa of six cigarette smokers who had received heavy occupational asbestos exposure with that in a group of six subjects with similar exposure who were never smokers. The groups were matched in terms of age, sex, years of exposure, and mean parenchymal amosite burden. We found that the concentration of amosite in airway mucosa was significantly elevated (by approximately sixfold) in smokers (p < 0.02). Chrysotile parenchymal burdens were statistically similar in both groups, but the chrysotile airway burden was again higher (by approximately 50-fold) in smokers (p < 0.006). There were no differences in airway or parenchymal tremolite burdens between the two groups. Fibers of all three types of asbestos recovered from the airway mucosa or parenchyma of smokers were shorter than fibers recovered from nonsmokers, an observation in accord with experimental data suggesting that cigarette smoke leads to retention of shorter fibers. These findings indicate that cigarette smoking causes enhanced accumulation of both amosite and chrysotile in the airway mucosa. This process may play a role in potentiating the pathologic effects of asbestos.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735593     DOI: 10.1164/ajrccm.151.5.7735593

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Effects of cigarette smoke and asbestos on airway, vascular and mesothelial cell proliferation.

Authors:  H Sekhon; J Wright; A Churg
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 2.  Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Authors:  Esther Barreiro; Víctor Bustamante; Víctor Curull; Joaquim Gea; José Luis López-Campos; Xavier Muñoz
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Molecular basis of asbestos-induced lung disease.

Authors:  Gang Liu; Paul Cheresh; David W Kamp
Journal:  Annu Rev Pathol       Date:  2013-01-24       Impact factor: 23.472

Review 4.  Asbestos and cancer: An overview of current trends in Europe.

Authors:  M Albin; C Magnani; S Krstev; E Rapiti; I Shefer
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

5.  Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea.

Authors:  Sanghyuk Im; Kan-Woo Youn; Donghee Shin; Myeoung-Jun Lee; Sang-Jun Choi
Journal:  Ann Occup Environ Med       Date:  2015-12-30

6.  Asbestos-induced lung disease in small-scale clutch manufacturing workers.

Authors:  Dipti Gothi; Tanushree Gahlot; Ram B Sah; Mayank Saxena; U C Ojha; Anand K Verma; Sonam Spalgais
Journal:  Indian J Occup Environ Med       Date:  2016 May-Aug

7.  Mesothelioma in an HIV/AIDS patient without history of asbestos exposure: possible role for immunosuppression in mesothelioma: a case report.

Authors:  Cleve Orian James; Ashanti W Woods; Payam Arya; Khadega Ahmed Abuelgasim; Lekidelu Taddesse Heath; Amy Sitapati
Journal:  Cases J       Date:  2009-05-11

Review 8.  Contribution of reactive oxygen and nitrogen species to particulate-induced lung injury.

Authors:  S Zhu; M Manuel; S Tanaka; N Choe; E Kagan; S Matalon
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

9.  Cigarette smoke represses the innate immune response to asbestos.

Authors:  Gilbert F Morris; Svitlana Danchuk; Yu Wang; Beibei Xu; Roy J Rando; Arnold R Brody; Bin Shan; Deborah E Sullivan
Journal:  Physiol Rep       Date:  2015-12

Review 10.  Asbestos, Smoking and Lung Cancer: An Update.

Authors:  Sonja Klebe; James Leigh; Douglas W Henderson; Markku Nurminen
Journal:  Int J Environ Res Public Health       Date:  2019-12-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.